RT Journal Article
SR Electronic
T1 Clinical, morphological, and molecular aspects of sialic acid storage disease manifesting in utero
JF Journal of Medical Genetics
JO J Med Genet
FD BMJ Publishing Group Ltd
SP 829
OP 836
DO 10.1136/jmg.2004.029744
VO 42
IS 11
A1 R Froissart
A1 D Cheillan
A1 R Bouvier
A1 S Tourret
A1 V Bonnet
A1 M Piraud
A1 I Maire
YR 2005
UL http://jmg.bmj.com/content/42/11/829.abstract
AB Background: Sialic acid storage diseases (SASDs) are caused by the defective transport of free sialic acid outside the lysosome. Apart from the Salla presentation in Finland, SASD is a very rare form of lysosomal storage disease (LSD) with approximately 35 cases, all diagnosed after birth, having been reported worldwide. We report a series of 12 French patients with very early manifestations, including eight fetuses diagnosed in utero. Results: Ultrasound examination, fetal autopsy, or clinical examination showed prominent ascites, rarely progressing to complete hydrops, and highlighted the early severity of bone disease. Dramatic increase of free sialic acid in various biological samples confirmed the diagnosis in all cases. Storage staining affinities and storage distribution in placenta and fetal organs allowed differential diagnosis from other LSDs but cannot differentiate between SASD, sialidosis, and galactosialidosis. Fourteen different mutations were identified, showing the molecular heterogeneity of SASD in the French population. We found that the previously described p.Y306X mutation generated two different transcripts, and we identified seven novel mutations: three deletions (del exon 7, del exons10+11 and c.1296delT), one splice site mutation (c.1350+1G→T) one nonsense mutation (p.W339X), and two missense mutations (p.R57C and p.G127E). Conclusions: The severity of our patients’ genotypes is in agreement with their phenotypes but not with the importance and early appearance of the very frequent in utero manifestations. Minimal fetal disease in some patients and a reported case of heterogeneity of fetal involvement within a family suggest that factors other than the genotype influence fetal manifestations.